{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:41:39Z","timestamp":1652881299484},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The percutaneous device closure of patent ductus arteriosus (PDA) is widely used in clinical practice, however full data on the changes in myocardial injury and systemic inflammatory markers\u2019 levels after PDA in children are not fully reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We have conducted a retrospective analysis of the medical records of 385 pediatric patients in our hospital from January 2017 to December 2019. The patients were distributed into five groups. The first four (A, B, C and D) included patients divided by the type of the surgical closure methods, namely ligation, clamping, ligation-combined suturing and ligation-combined clamping, respectively. The fifth group E comprised of percutaneous device PDA patients. All recorded medical and trial data from the five groups were statistically studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No serious complications in the patients regardless of the classification group were reported. Our results suggested that there were no considerable differences between the groups at the baseline (with all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). Group E demonstrated a significantly smaller operative time (42.39\u2009\u00b1\u20093.88, min) and length of hospital stay (LOS) (4.49\u2009\u00b1\u20090.50, day), less intraoperative blood loss (7.12\u2009\u00b1\u20092.09, ml) while on the other hand, a higher total hospital cost (24,001.35\u2009\u00b1\u20091152.80, RMB) than the other four groups (with all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Interestingly, the comparison of the inflammatory factors such as white blood cells (WBC) count, C-reactive protein (CRP), procalcitonin (PCT) and interleukin-6 (IL-6), as well as the myocardial injury markers (CKMB and troponin I) did not show a significant increase (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05) among the four groups. On the contrary, when the aforementioned factors and markers of all the surgical groups were compared to those in group E, we observed significantly higher speed and magnitude of changes in group E than those in groups A, B, C, and D (with all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although the percutaneous device closure of PDA is more comforting and drives fast recuperation in comparison to conventional surgery, it provokes myocardial injury and overall inflammation. Timely substantial and aggressive intervention measures such as the use of antibiotics before operation and active glucocorticoids to suppress inflammation and nourish the myocardium need be applied if the myocardial and inflammatory markers are eminent.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02666-x","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:03:04Z","timestamp":1652878984000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus"],"prefix":"10.1186","volume":"22","author":[{"given":"Zeng-Rong","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Zhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"2666_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1203\/00006450-197209000-00001","volume":"6","author":"I Oberh\u00e4nsli-Weiss","year":"1972","unstructured":"Oberh\u00e4nsli-Weiss I, Heymann MA, Rudolph AM, Melmon KL. The pattern and mechanisms of response to oxygen by the ductus arteriosus and umbilical artery. Pediatr Res. 1972;6:693\u2013700.","journal-title":"Pediatr Res"},{"key":"2666_CR2","first-page":"138","volume":"12","author":"E James","year":"2007","unstructured":"James E. Dice, Jatinder Bhatia: patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther. 2007;12:138\u201346.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2666_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1053\/j.semperi.2011.09.025","volume":"36","author":"J Douglas","year":"2012","unstructured":"Douglas J. Schneider: the patent ductus arteriosus in term infants, children, and adults. Semin Perinatol. 2012;36:146\u201353.","journal-title":"Semin Perinatol"},{"key":"2666_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.5603\/KP.a2018.0038","volume":"76","author":"I Haponiuk","year":"2018","unstructured":"Haponiuk I, Jaworski R, Paczkowski K, Chojnicki M, Steffens M, Szofer-Sendrowska A, et al. Postoperative kinetics of common inflammatory biomarkers after congenital heart defect procedures with extracorporeal circulation in children. Kardiol Pol. 2018;76:968\u201373.","journal-title":"Kardiol Pol"},{"key":"2666_CR5","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","volume":"31","author":"H Baumgartner","year":"2010","unstructured":"Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE, Galie N, et al. ESC\u00a0Guidelines for the\u00a0management\u00a0of\u00a0grown-up\u00a0congenital heart disease\u00a0(new\u00a0version\u00a02010). Eur Heart J. 2010;31:2915\u201357.","journal-title":"Eur Heart J"},{"key":"2666_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PCC.0000000000001118","volume":"18","author":"X Li","year":"2017","unstructured":"Li X, Wang X, Li S, Yan J, Li D. Diagnostic\u00a0value\u00a0of\u00a0procalcitonin\u00a0on\u00a0early\u00a0postoperative\u00a0infection\u00a0after\u00a0pediatric\u00a0cardiac surgery. Pediatr Crit Care Med. 2017;18:420\u20138.","journal-title":"Pediatr Crit Care Med"},{"key":"2666_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S1047951101000476","volume":"11","author":"PJ Kannankeril","year":"2001","unstructured":"Kannankeril PJ, Wax DF, Pahl E. Elevations\u00a0of\u00a0troponin I\u00a0after\u00a0interventional\u00a0cardiac catheterization. Cardiol Young. 2001;11:375\u20138.","journal-title":"Cardiol Young"},{"key":"2666_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13019-019-0900-4","volume":"14","author":"JS Huang","year":"2019","unstructured":"Huang JS, Chen Q, Chen LW, Kuo YR, Hong ZN, Cao H. Changes in the levels of inflammatory markers after transthoracic device closure of ventricular septal defects in pediatric patients. J Cardiothorac Surg. 2019;14:70.","journal-title":"J Cardiothorac Surg"},{"key":"2666_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/heart.83.4.371","volume":"83","author":"SJ Maynard","year":"2000","unstructured":"Maynard SJ, Menown IB, Adgey AA. Troponin T or troponin I as cardiac markers in ischaemic heart disease. Heart. 2000;83:371\u20133.","journal-title":"Heart"},{"key":"2666_CR10","first-page":"193","volume":"9","author":"SM Saadeddin","year":"2003","unstructured":"Saadeddin SM, Habbab MA. Percutaneous coronary intervention in the context of systemic inflammation: more injury and worse outcome. Med Sci Monit. 2003;9:193\u20137.","journal-title":"Med Sci Monit"},{"key":"2666_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00024382-200116001-00007","volume":"16","author":"F Harig","year":"2001","unstructured":"Harig F, Hohenstein B, von der Emde J, Weyand M. Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. Shock. 2001;16:33\u20138.","journal-title":"Shock"},{"key":"2666_CR12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0022-5223(96)70068-5","volume":"112","author":"S Wan","year":"1996","unstructured":"Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory markers in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112:806\u201311.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2666_CR13","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1007\/s00380-016-0807-0","volume":"31","author":"K Miyamoto","year":"2016","unstructured":"Miyamoto K, Takeuchi D, Inai K, Shinohara T, Nakanishi T. Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heartdisease: comparisons of single\u2212\/two-ventricle physiology, and systemic morphologically right\/left ventricles. Heart Vessels. 2016;31:1834\u201347.","journal-title":"Heart Vessels"},{"key":"2666_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0167-5699(94)90138-4","volume":"15","author":"DM Steel","year":"1994","unstructured":"Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15:81\u20138.","journal-title":"Immunol Today"},{"key":"2666_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jocs.12465","volume":"30","author":"M G\u00fcvener","year":"2015","unstructured":"G\u00fcvener M, Korun O, Demirt\u00fcrk OS. Risk factors for systemic inflammatory response after congenital cardiac surgery. J Card Surg. 2015;30:92\u20136.","journal-title":"J Card Surg"},{"key":"2666_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jocs.12465","volume":"30","author":"AB Madhok","year":"2015","unstructured":"Madhok AB, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. J Card Surg. 2015;30:92\u20136.","journal-title":"J Card Surg"},{"key":"2666_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1532\/hsf.1932","volume":"21","author":"ZW Lin","year":"2018","unstructured":"Lin ZW, Chen Q, Cao H, et al. The short and midterm follow-up of transthoracic device closure of Perimembranous ventricular septal defect in adults. Heart Surg Forum. 2018;21:242\u20136.","journal-title":"Heart Surg Forum"},{"key":"2666_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/joic.12121","volume":"27","author":"L Yang","year":"2014","unstructured":"Yang L, Tai BC, Khin LW, Quek SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol. 2014;27:260\u201372.","journal-title":"J Interv Cardiol"},{"key":"2666_CR19","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1253\/circj.CJ-12-0111","volume":"76","author":"M Polomsky","year":"2012","unstructured":"Polomsky M, Puskas JD. Off-pump coronary artery bypass grafting-the current state. Circ J. 2012;76:784\u201390.","journal-title":"Circ J"},{"key":"2666_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.advms.2013.06.001","volume":"59","author":"R Jaworski","year":"2014","unstructured":"Jaworski R, Haponiuk I, Irga-Jaworska N, et al. Kinetics of C-reactive protein in children with congenital heart diseases in the early period aftercardiosurgical treatment with extracorporeal circulation. Adv Med Sci. 2014;59:19\u201322.","journal-title":"Adv Med Sci"},{"issue":"220","key":"2666_CR21","first-page":"e11","volume":"27","author":"E Nahum","year":"2012","unstructured":"Nahum E, Schiller O, Livni G, Bitan S, Ashkenazi S, Dagan O. Procalcitonin level as an aid for the diagnosis of bacterial infections following pediatric cardiac surgery. J Crit Care. 2012;27(220):e11\u20136.","journal-title":"J Crit Care"},{"key":"2666_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.1939.02800080049011","volume":"112","author":"RE Gross","year":"1939","unstructured":"Gross RE, Hubbard JP. Surgical ligation of a patent ductus arteriosus: report of first successful case. JAMA. 1939;112:729\u201331.","journal-title":"JAMA"},{"key":"2666_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/0974-2069.126560","volume":"7","author":"E Tefera","year":"2014","unstructured":"Tefera E, Bermudez-Ca\u00f1ete R. Percutaneous closure of patent ductus arteriosus in interrupted inferior caval vein through femoral vein approach. Ann Pediatr Cardiol. 2014;7:55\u20137.","journal-title":"Ann Pediatr Cardiol"},{"key":"2666_CR24","first-page":"132","volume":"9","author":"J Kusa","year":"2013","unstructured":"Kusa J, Ra\u015b M, Cze\u015bniewicz P, Nahirny R. Less invasive percutaneous closure of persistent arterial duct in children below 10 kilos. Postepy Kardiol Interwencyjnej. 2013;9:132\u20135.","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"2666_CR25","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0003-4975(98)00795-4","volume":"66","author":"FF Immer","year":"1998","unstructured":"Immer FF, Stocker FP, Seiler AM, Pfammatter J, Printzen G, Carrel TP. Comparison of troponin-I and troponin-T after pediatric cardiovascular operation. Ann Thorac Surg. 1998;66:2073\u20137.","journal-title":"Ann Thorac Surg"},{"key":"2666_CR26","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0735-1097(99)00061-3","volume":"33","author":"FF Immer","year":"1999","unstructured":"Immer FF, Stocker FP, Seiler AM, Pfammatter J, Bachmann D, Printzen G, et al. Troponin-I for prediction of early postoperative course after pediatric cardiac surgery. J Am Coll Cardiol. 1999;33:1719\u201323.","journal-title":"J Am Coll Cardiol"},{"key":"2666_CR27","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/S0003-4975(98)00228-8","volume":"65","author":"R Hirsch","year":"1988","unstructured":"Hirsch R, Dent CL, Wood MK, Huddleston CB, Mendeloff EN, Balzer DT, et al. Patterns and potential value of cardiac troponin I elevations after pediatric cardiac operations. Ann Thorac Surg. 1988;65:1394\u20139.","journal-title":"Ann Thorac Surg"},{"key":"2666_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s100240050007","volume":"3","author":"VL Montgomery","year":"2000","unstructured":"Montgomery VL, Sullivan JE, Buchino JJ. Prognostic value of pre- and postoperative cardiac troponin I measurement in children having cardiac surgery. Pediatr Dev Pathol. 2000;3:53\u201360.","journal-title":"Pediatr Dev Pathol"},{"key":"2666_CR29","first-page":"853","volume":"130","author":"JA Towbin","year":"1997","unstructured":"Towbin JA, Gajarski RJ. Cardiac troponin I: a new diagnostic gold standard of cardiac injury in children? J Pediatr. 1997;130:853\u20135.","journal-title":"J Pediatr"},{"key":"2666_CR30","doi-asserted-by":"publisher","first-page":"558256","DOI":"10.3389\/fped.2020.558256","volume":"8","author":"A Fraisse","year":"2020","unstructured":"Fraisse A, Bautista-Rodriguez C, Burmester M, Lane M, Singh Y. Transcatheter closure of patent ductus arteriosus in infants with weight under 1500 grams. Front Pediatr. 2020;8:558256.","journal-title":"Front Pediatr"},{"key":"2666_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0002-9149(00)01221-2","volume":"86","author":"JF Rhodes","year":"2000","unstructured":"Rhodes JF, Asnes JD, Blaufox AD, Sommer RJ. Impact of low body weight on frequency of pediatric cardiac catheterization complications. Am J Cardiol. 2000;86:1275\u20138.","journal-title":"Am J Cardiol"},{"key":"2666_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0022-5223(97)70231-9","volume":"113","author":"DP Taggart","year":"1997","unstructured":"Taggart DP, Hadjinikolas L, Hooper J, Albert J, Kemp M, Hue D, et al. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J Thorac Cardiovasc Surg. 1997;113:728\u201335.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2666_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0002-9149(02)02781-9","volume":"90","author":"J Prince","year":"2002","unstructured":"Prince J, et al. Usefulness of troponin I as a marker of myocardial injury after pediatric cardiac catheterization. Am J Cardiol. 2002;90:1128\u201332.","journal-title":"Am J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02666-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02666-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:04:21Z","timestamp":1652879061000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02666-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2666"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02666-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that all methods were carried out in accordance with relevant guidelines and regulations. Ethics committee of Union Hospital of Fujian Medical University waived the need for informed consent based on the study\u2019s retrospective analysis of patient data. All experimental\u00a0protocols of this study were approved by the ethics committee of Union Hospital of Fujian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}